These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6616018)

  • 1. Determination of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in plasma by negative chemical ionization mass spectrometry.
    Smith RG; Cheung LK; Feun LG; Loo TL
    Biomed Mass Spectrom; 1983 Jul; 10(7):404-7. PubMed ID: 6616018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetics of 1-(2-chloroethyl)-3-(2,6-dioxo-1-piperidyl)-1-nitrosourea in rats and patients and extrapolation to clinical trials.
    Levin VA; Liu J; Weinkam RJ
    Cancer Res; 1981 Sep; 41(9 Pt 1):3475-7. PubMed ID: 7020928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological disposition of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in mice.
    Rahman A; Luc PV; Schein PS; Woolley PV
    Cancer Res; 1984 Jan; 44(1):149-53. PubMed ID: 6690033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU.
    Levin VA; Stearns J; Byrd A; Finn A; Weinkam RJ
    J Pharmacol Exp Ther; 1979 Jan; 208(1):1-6. PubMed ID: 759602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation study of assay method for DX-8951 and its metabolite in human plasma and urine by high-performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry.
    Oguma T; Konno T; Inaba A; Nakaoka M
    Biomed Chromatogr; 2001 Apr; 15(2):108-15. PubMed ID: 11268051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of LY355703 in dog and mouse plasma by positive ion liquid chromatography/tandem mass spectrometry with atmospheric pressure chemical ionization.
    Berna M; Shugert R; Mullen J
    J Mass Spectrom; 1998 Feb; 33(2):138-43. PubMed ID: 9487688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in patients with metastatic colorectal cancer.
    Bedikian AY; Stroehlein JR; Karlin DA; Bennetts RW; Stewart DJ; Bodey GP
    Am J Clin Oncol; 1983 Feb; 6(1):49-52. PubMed ID: 6837507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in small cell cancer of the lung.
    Chapman RA; Natale RB; Young CW; Wittes RE
    Am J Clin Oncol; 1984 Oct; 7(5):413-4. PubMed ID: 6095639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-(piperidyl)-1 nitrosourea (PCNU)(NSC-95466) in patients with advanced carcinoma of the lung.
    Ratanatharathorn V; Samson MK; Haas CD; Cummings GD; O'Connor EJ; Baker LH
    Am J Clin Oncol; 1983 Feb; 6(1):99-102. PubMed ID: 6837509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of derivatized l-alanosine in plasma by liquid chromatography-tandem mass spectrometry.
    Gantverg A; Elliott G; Pineault J; Demers R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 803(2):311-5. PubMed ID: 15063341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lethal activity and repair inhibition capacity of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (NSC 95466, PCNU), a nitrosourea with low carbamoylating activity.
    Drewinko B; Yang LY
    Invest New Drugs; 1983; 1(3):197-202. PubMed ID: 6678867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein mediated chemical reactions of chloroethylnitrosoureas.
    Weinkam RJ; Liu TY; Lin HS
    Chem Biol Interact; 1980 Aug; 31(2):167-77. PubMed ID: 7389008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial and clinical pharmacology of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea.
    Woolley PV; Luc PV; Rahman A; Korsmeyer SJ; Smith FP; Schein PS
    Cancer Res; 1981 Oct; 41(10):3896-900. PubMed ID: 7284999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of L-654,066, a new 5 alpha-reductase inhibitor in plasma by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry.
    Gilbert JD; Olah TV; Barrish A; Greber TF
    Biol Mass Spectrom; 1992 Jul; 21(7):341-6. PubMed ID: 1420375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic disposition of 2-chloroethyl nitrosocarbamoylcystamine in rats.
    Godeneche D; Madelmont JC; Moreau MF; Duprat J; Chabard JL; Plagne R; Meyniel G
    Drug Metab Dispos; 1985; 13(2):220-6. PubMed ID: 2859172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-chloroethanol formation as evidence for a 2-chloroethyl alkylating intermediate during chemical degradation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea.
    Reed DJ; May HE; Boose RB; Gregory KM; Beilstein MA
    Cancer Res; 1975 Mar; 35(3):568-76. PubMed ID: 1116123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A liquid chromatography-mass spectrometry assay for simultaneous determination of two antimalarial thiazolium compounds in human and rat matrices.
    Taudon N; Margout D; Calas M; Kezutyte T; Vial HJ; Bressolle FM
    J Pharm Biomed Anal; 2008 Nov; 48(3):1001-5. PubMed ID: 18678456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative determination of 1-2(chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea in blood and urine of man.
    Nakajima O; Yoshida Y; Kubota T; Takemasa Y; Koyama Y
    J Chromatogr; 1982 May; 229(2):481-6. PubMed ID: 6212589
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative thin-layer chromatography/mass spectrometry analysis of caffeine using a surface sampling probe electrospray ionization tandem mass spectrometry system.
    Ford MJ; Deibel MA; Tomkins BA; Van Berkel GJ
    Anal Chem; 2005 Jul; 77(14):4385-9. PubMed ID: 16013850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly sensitive method for the determination of a novel triple kinase inhibitor with anti-cancer activity, JI-101, in rat plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pharmacokinetic study.
    Gurav SD; Gilibili RR; Jeniffer S; Giri S; Srinivas NR; Mullangi R
    Biomed Chromatogr; 2011 Jul; 25(7):794-800. PubMed ID: 20872957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.